A $2.36 billion record backlog and a transformative pending acquisition are quietly building a very different investment case for Rocket Lab (NASDAQ: RKLB) than its rockets alone would suggest.

Space Systems generated $189.5 million in second-quarter revenue, more than four times the $44.6 million produced by the company’s much-publicized launch operations during the same period.

That revenue split is central to understanding where the company is actually heading, with the pending Iridium Communications (NASDAQ: IRDM) acquisition set to accelerate the shift even further toward recurring, subscription-based income.

Iridium stockholders approved the transaction on September 24, 2026, and the deal is expected to close around mid-2027, bringing with it 66 satellites, more than 2.5 million subscribers, and over $870 million in annual revenue.

CEO Peter Beck frames the strategic logic plainly, describing the space economy as three distinct businesses and stating, “With Iridium, Rocket Lab will have all three of these verticals.”

The combination of satellite hardware, launch capability, and a large communications subscriber base would give Rocket Lab a vertical integration story that few space companies can credibly claim.

Defense spending adds further ballast, with a $397 million Flatellite contract from the Space Force, more than $160 million to construct three geostationary satellites, and over $1 billion in fresh contracts awarded during the third quarter alone.

Second-quarter revenue reached $234.07 million, a 62% jump from a year earlier that edged past the $230.94 million analyst consensus, while Q3 guidance calls for $250 million to $265 million with results expected around November 9.

Despite that operational momentum, the stock trades around $60.20, roughly 60% below its 52-week high of $151 and down 13.7% year to date, even after a 12.17% gain over the past week.

A 12-month price target of $110.63 from 24/7 Wall St. implies 83.8% upside from current levels, supported by an analyst consensus target of $102.15 drawn from 4 Strong Buy, 12 Buy, and 4 Hold ratings with zero Sell recommendations.

The bull case extends to $155.01, a gain of 157.5%, contingent on the Neutron rocket achieving its first successful flight and Iridium integrating without disruption, while even the bear case of $87.58 sits 45.5% above where the stock trades today.

Risks are real: the company lost $198 million in FY25, raised $1.53 billion through share sales in the first half of 2026, and Neutron already suffered one delay following a tank test failure, with third-quarter gross margin guidance of 35% to 37% trailing the 41.5% posted in Q2.

At 48 times sales, the valuation leaves little margin for execution stumbles, though the adjusted EBITDA loss has already narrowed sharply, from $27.6 million to $8.8 million, and the company holds $2.13 billion in cash.

Peer comparisons place Rocket Lab in a middle position: Planet Labs (NYSE: PL) trades at just 13.78 times sales despite posting 58.1% quarterly revenue growth, while AST SpaceMobile (NASDAQ: ASTS) commands 141.63 times sales on only $115.3 million in trailing revenue.

That positioning makes the current valuation look neither egregiously stretched nor conservatively priced, with the Iridium close and Neutron’s launch cadence serving as the two variables most likely to determine which direction the stock resolves.